News
Trump administration funding cuts and dismantling of USAID force a shift from HIV elimination back to treatment.
The UNAIDS annual report warns that Trump era HIV funding cuts could lead to 6 million more infections and 4 million deaths ...
HIV jab has signed a deal to supply the costly injection at a knock-down price to as many as two million people in poorer countries.
A new report says the withdrawal of U.S. funding has caused a “systemic shock” to the global effort against AIDS and HIV.
Gilead has partnered with Global Fund to supply lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP).
11h
Health and Me on MSNUN Warns Millions Could Die By 2029 If US Cuts HIV FundingU.S. HIV funding cuts risk reversing decades of progress, potentially causing over 4 million AIDS-related deaths and 6 ...
The first lenacapavir jabs will be delivered later this year under a new agreement between Gilead Sciences and the Global Fund ...
Lenacapavir is available in both oral tablet form and as subcutaneous injections. It is available as oral tablets and ...
A new report by the U.N. AIDS agency says the sudden withdrawal of U.S. funding has caused a “systemic shock” to the global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results